The Journal of Molecular Biology is a biweekly peer-reviewed scientific journal covering all aspects of molecular biology. It was established in 1959 and is published by Elsevier. The editor-in-chief is Peter Wright.
The EMBO Journal is a semi-monthly peer-reviewed scientific journal focusing on full-length papers describing original research of general interest in molecular biology and related areas. The editor-in-chief is Facundo D. Batista.
PLOS Genetics is a peer-reviewed open access scientific journal established in 2005 and published by the Public Library of Science. The founding editor-in-chief was Wayne N. Frankel. The current editors-in-chief are Gregory S. Barsh and Gregory P. Copenhaver. The journal covers research on all aspects of genetics and genomics.
Cancer Research is a biweekly peer-reviewed medical journal published by the American Association for Cancer Research. It covers research on all aspects of cancer and cancer-related biomedical sciences and was established in 1941. The editor-in-chief is Chi Van Dang.
The American Journal of Public Health is a monthly peer-reviewed public health journal published by the American Public Health Association that covers health policy and public health. The journal was established in 1911 and its stated mission is "to advance public health research, policy, practice, and education." The journal occasionally publishes themed supplements. The editor-in-chief is Alfredo Morabia.
Clinical Microbiology Reviews is a peer-reviewed medical journal covering the areas of clinical microbiology, immunology, medical microbiology, infectious diseases, veterinary microbiology, and microbial pathogenesis. It is a delayed open access journal, full content is accessible via PubMed Central and the journal's website after a 12-month embargo. In April 2015, the journal transitioned to a continuous online publication model. The journal became online-only in January 2018. The final print issue was published in October 2017. According to the Journal Citation Reports, the journal has a 2021 impact factor of 50.129. The journal was established in January 1988. The founding editor was Josephine A. Morello. Editorial board structure changed in 1992 and Morello became editor-in-chief. Betty Ann Forbes was appointed editor-in-chief in 1997. Irving Nachamkin was appointed editor-in-chief in 2002 until 2012. Since 2012, Jo-Anne H. Young has served as editor-in-chief. It is the ninth journal established and published by the American Society for Microbiology.
The Journal of Immunology is a biweekly peer-reviewed medical journal that publishes basic and clinical studies in all aspects of immunology. Established in 1916, it changed its name to Journal of Immunology, Virus Research and Experimental Chemotherapy from 1943 to 1949, then returned to the original Journal of Immunology in 1950. It is the official journal of the American Association of Immunologists. The editor-in-chief is Eugene M. Oltz.
Acta Paediatrica is a monthly peer-reviewed medical journal covering paediatrics. It is published by Wiley-Blackwell on behalf of the Foundation Acta Paediatrica, based at the Karolinska Institute in Sweden.
The International Journal of Clinical and Experimental Pathology is an open access medical journal established in 2008. It covers all aspects of experimental and clinical pathology and publishes review articles, original research articles, case reports, and editorials. It is published by e-Century Publishing Corporation. The co-editors-in-chief are Dennis W. Dickson, Mayo Clinic in Florida and Xiuwu Bian, Third Military Medical University, Chongqing, China. The journal is abstracted and indexed in Chemical Abstracts, Scopus, BIOSIS Previews, PubMed and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.706.
The American Journal of Translational Research is an open-access medical journal published by e-Century Publishing Corporation. The journal covers translational research of medical science and the relevant biomedical research areas. It was established in 2009. The editor-in-chief is Wen-Hwa Lee. The journal's main focus is original clinical and experimental research articles, but it also publishes review articles, editorials, hypotheses, letters to the editor, and meeting reports.
Neuroscience is a peer-reviewed scientific journal of neuroscience. It was established in 1976 with P.G. Kostyuk, Rodolfo Llinás, and A.D. Smith as founding editors-in-chief and originally published by Pergamon Press. The current editor-in-chief is Juan Lerma Gómez. The journal is published by Elsevier on behalf of the International Brain Research Organization (IBRO).
Hypertension is a monthly peer-reviewed scientific journal that was established in 1979. It is published on behalf of the American Heart Association by Lippincott Williams & Wilkins. The editor-in-chief is Rhian M. Touyz. The journal publishes original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letters to the editor, and novel findings of unusual interest. It covers all aspects of research on hypertension, including pathophysiology, blood pressure regulation, clinical treatment, and prevention.
Biomaterials is a peer-reviewed scientific journal covering research on and applications of biomaterials. It is published by Elsevier and the editor-in-chief is Kam W. Leong. The journal was established in 1980.
The European Journal of Endocrinology is a monthly peer-reviewed medical journal covering endocrinology with a focus on clinical and translational studies, research, and reviews in paediatric and adult endocrinology. It is the clinical journal of the European Society of Endocrinology. The editor-in-chief is Wiebke Arlt. The journal has been published by Bioscientifica since 1999.
Gary S. Firestein is an American rheumatologist, professor, and founding director of the Altman Clinical and Translational Research Institute (ACTRI) at the University of California San Diego and Senior Associate Vice Chancellor for Health Sciences at University of California, San Diego.
Genome Medicine is a peer-reviewed open-access medical journal with a focus on medical genetics. It was established in 2009 as a companion journal to Genome Biology and is published continuously by BioMed Central. The editor-in-chief is Rabia Begum.
The International Journal of Occupational and Environmental Health was a quarterly peer-reviewed public health journal with a focus on occupational and environmental health. It was established in 1995 and was published by Routledge. The last editor-in-chief was Andrew Maier.
The Journal of Clinical Periodontology is a monthly peer-reviewed medical journal covering periodontology. It is published by John Wiley & Sons. It was established in 1974 by the British, Dutch, French, German, Scandinavian, and Swiss periodontology societies and is an official journal of the European Federation of Periodontology. Articles are published in English. The editor-in-chief is Panos N. Papapanou. Currently, the Journal is ranked #1 out of 92 in Dentistry, Oral Surgery & Medicine.
Animal Bioscience is a monthly peer-reviewed open access scientific journal covering research in animal science. It was established in 1988 as the Asian-Australasian Journal of Animal Sciences, obtaining its current name in 2021. It is published by the Asian-Australasian Association of Animal Production Societies and the editors-in-chief are Jong Kyu Ha and Cheol-Heui Yun.
Richard B. Gaynor is an American physician specializing in hematology-oncology, educator, drug developer, and business executive. He served as an Associate Professor of Medicine at UCLA School of Medicine for nearly a decade, and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB, IκB kinase, and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies, with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half, he worked at Eli Lilly and Company, where he became the Senior Vice President of Oncology Clinical Development and Medical Affairs in 2013. Gaynor was President of R&D at Neon Therapeutics from 2016 to 2020, when he became the President of BioNTech US, both pharmaceutical companies headquartered in Cambridge, MA. His honors include being elected a member of the American Society for Clinical Investigation, and the Association of American Physicians.
